Return On Equity of Larimar Therapeutics, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Larimar Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Larimar Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -92%, a 156% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2024 was -40%, a 2.2% decline from 2023.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2023 was -39%, a 7.5% increase from 2022.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2022 was -42%, a 41% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Larimar Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -92% -56% -156% 01 Jul 2025 30 Sep 2025
Q2 2025 -63% -25% -66% 01 Apr 2025 30 Jun 2025
Q1 2025 -52% -17% -47% 01 Jan 2025 31 Mar 2025
Q4 2024 -40% -1% -2.2% 01 Oct 2024 31 Dec 2024
Q3 2024 -36% -3% -10% 01 Jul 2024 30 Sep 2024
Q2 2024 -38% -8% -26% 01 Apr 2024 30 Jun 2024
Q1 2024 -36% -2% -4.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -39% +3% +7.5% 01 Oct 2023 31 Dec 2023
Q3 2023 -33% +16% +33% 01 Jul 2023 30 Sep 2023
Q2 2023 -30% +42% +58% 01 Apr 2023 30 Jun 2023
Q1 2023 -34% +39% +53% 01 Jan 2023 31 Mar 2023
Q4 2022 -42% +30% +41% 01 Oct 2022 31 Dec 2022
Q3 2022 -48% +24% +33% 01 Jul 2022 30 Sep 2022
Q2 2022 -72% -13% -23% 01 Apr 2022 30 Jun 2022
Q1 2022 -73% -23% -46% 01 Jan 2022 31 Mar 2022
Q4 2021 -72% -16% -29% 01 Oct 2021 31 Dec 2021
Q3 2021 -72% -7% -10% 01 Jul 2021 30 Sep 2021
Q2 2021 -58% +59% +50% 01 Apr 2021 30 Jun 2021
Q1 2021 -50% +2574% +98% 01 Jan 2021 31 Mar 2021
Q4 2020 -55% +3218% +98% 01 Oct 2020 31 Dec 2020
Q3 2020 -66% +1858% +97% 01 Jul 2020 30 Sep 2020
Q2 2020 -117% +23% +17% 01 Apr 2020 30 Jun 2020
Q1 2020 -2624% -2499% -1995% 01 Jan 2020 31 Mar 2020
Q4 2019 -3274% -3164% -2886% 01 Oct 2019 31 Dec 2019
Q3 2019 -1923% -1843% -2302% 01 Jul 2019 30 Sep 2019
Q2 2019 -140% -59% -74% 01 Apr 2019 30 Jun 2019
Q1 2019 -125% -59% -89% 01 Jan 2019 31 Mar 2019
Q4 2018 -110% -55% -99% 01 Oct 2018 31 Dec 2018
Q3 2018 -80% -33% -71% 01 Jul 2018 30 Sep 2018
Q2 2018 -81% -36% -81% 01 Apr 2018 30 Jun 2018
Q1 2018 -66% -24% -57% 01 Jan 2018 31 Mar 2018
Q4 2017 -55% -13% -31% 01 Oct 2017 31 Dec 2017
Q3 2017 -47% +1% +1.1% 01 Jul 2017 30 Sep 2017
Q2 2017 -45% +2% +3.7% 01 Apr 2017 30 Jun 2017
Q1 2017 -42% +2% +3.6% 01 Jan 2017 31 Mar 2017
Q4 2016 -42% -4% -12% 01 Oct 2016 31 Dec 2016
Q3 2016 -47% -13% -38% 01 Jul 2016 30 Sep 2016
Q2 2016 -46% -11% -31% 01 Apr 2016 30 Jun 2016
Q1 2016 -44% -11% -35% 01 Jan 2016 31 Mar 2016
Q4 2015 -38% 01 Oct 2015 31 Dec 2015
Q3 2015 -34% 01 Jul 2015 30 Sep 2015
Q2 2015 -35% 01 Apr 2015 30 Jun 2015
Q1 2015 -32% 01 Jan 2015 31 Mar 2015

Larimar Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -40% -1% -2.2% 01 Jan 2024 31 Dec 2024
2023 -39% +3% +7.5% 01 Jan 2023 31 Dec 2023
2022 -42% +30% +41% 01 Jan 2022 31 Dec 2022
2021 -72% -16% -29% 01 Jan 2021 31 Dec 2021
2020 -55% +3060% +98% 01 Jan 2020 31 Dec 2020
2019 -3115% -3006% -2741% 01 Jan 2019 31 Dec 2019
2018 -110% -55% -99% 01 Jan 2018 31 Dec 2018
2017 -55% -13% -31% 01 Jan 2017 31 Dec 2017
2016 -42% -4% -12% 01 Jan 2016 31 Dec 2016
2015 -38% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.